Our 2014 Performance
Revenues––2014
Revenues in 2014 were $49.6 billion, a decrease of 4% compared to 2013, which reflects an operational decrease of $1.1 billion, or 2%, and
the unfavorable impact of foreign exchange of $912 million, or 2%. See the "Analysis of the Consolidated Statements of Income––
Revenues––Overview" section below for more information, including a discussion of key drivers of our revenue performance
yeah, those poor babies only made 49.6 billion last year ... pfuck Pfizer.